{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:35:29Z","timestamp":1778254529569,"version":"3.51.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/04927-8"],"award-info":[{"award-number":["2019\/04927-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Li-Fraumeni syndrome (LFS) is a pan-cancer predisposition syndrome caused by germline pathogenic variants in the gene TP53. The interpretation of TP53 variants in clinical scenarios outside the classic LFS criteria may be challenging. Here, we report a patient affected by 2 primary cancers at later ages, who harbored a likely pathogenic TP53 at low allele frequency detected in a blood sample.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Molecular Tumor Board committee at our institution revisited the case of a patient who was enrolled in a research protocol for the investigation of genetic conditions associated with neuroendocrine tumors. Clinical, familial, and molecular data were reviewed. The patient received germline testing using a next generation sequencing multi-gene panel and was incidentally found to harbor a TP53 likely pathogenic variant, with 22% of variant allele fraction. Additional samples, including a second blood sample, oral swab, and saliva, were collected for DNA analysis. A new TP53 sequencing round was performed with the attempt to distinguish between a true constitutional germline variant and a somatically acquired variant due to aberrant clonal expansion of bone marrow precursors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patient\u2019s personal and familial history of cancer did not meet classic nor Chompret LFS criteria. Environmental risk factors for cancer were identified, such as alcohol abuse and tobacco exposure. The TP53 variant initially found in the next-generation sequencing was confirmed by Sanger sequencing in the previous DNA sample extracted from blood for the first analysis and in a second blood sample collected 6 years later. The TP53 variant was not detected in the DNA extracted from the oral swab and saliva samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Considering the low TP53 variant allele fraction in blood, absence of variant detection in oral swab and saliva samples, the lack of LFS clinical criteria, and history of exposure to environmental risk factors for cancer, the main hypothesis for this case was aberrant clonal expansion due to clonal hematopoiesis. Oncologists should interpret TP53 findings during germline testing with caution.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyad105","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T03:12:14Z","timestamp":1683774734000},"page":"624-627","source":"Crossref","is-referenced-by-count":4,"title":["Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-8011","authenticated-orcid":false,"given":"Camila B","family":"Xavier","sequence":"first","affiliation":[{"name":"Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudinei","family":"Link","sequence":"additional","affiliation":[{"name":"Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon\u00edlia","family":"Abreu","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Bettoni","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiane","family":"Marson","sequence":"additional","affiliation":[{"name":"Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro A F","family":"Galante","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibele","family":"Masotti","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariane T","family":"Amano","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius","family":"de Molla","sequence":"additional","affiliation":[{"name":"Hematology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamaria A","family":"Camargo","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula F","family":"Asprino","sequence":"additional","affiliation":[{"name":"Molecular Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Sabbaga","sequence":"additional","affiliation":[{"name":"Oncology Center, Hospital S\u00edrio-Liban\u00eas , S\u00e3o Paulo, SP , Brazil"},{"name":"Instituto do C\u00e2ncer do Estado de S\u00e3o Paulo, Universidade de S\u00e3o Paulo , S\u00e3o Paulo, SP , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"2","key":"2023070520003099000_CIT0001","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/ERC-17-0286","article-title":"TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias","volume":"25","author":"Asprino","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2023070520003099000_CIT0002","volume-title":"Genomics in the Cloud: Using Docker, GATK, and WDL in Terra","author":"Van der Auwera","year":"2020"},{"issue":"W1","key":"2023070520003099000_CIT0003","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.1093\/nar\/gks539","article-title":"SIFT web server: predicting effects of amino acid substitutions on proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2023070520003099000_CIT0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"7809","key":"2023070520003099000_CIT0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"D1","key":"2023070520003099000_CIT0006","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2023070520003099000_CIT0007","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/humu.24152","article-title":"Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants","volume":"42","author":"Fortuno","year":"2021","journal-title":"Hum Mutat"},{"issue":"23","key":"2023070520003099000_CIT0008","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen\u2014The Clinical Genome Resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"2023070520003099000_CIT0009"},{"key":"2023070520003099000_CIT0010","author":"de Andrade"},{"issue":"23","key":"2023070520003099000_CIT0011","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort: cancer risk in TP53 mutation carriers","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"2023070520003099000_CIT0012","first-page":"1723","article-title":"Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history","volume-title":"Hum Mutat","author":"de Andrade","year":"2017"},{"issue":"1","key":"2023070520003099000_CIT0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2023070520003099000_CIT0014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000489042","article-title":"ICUS, IDUS, CHIP and CCUS: diagnostic criteria, separation from MDS and clinical implications","volume":"86","author":"Valent","year":"2019","journal-title":"Pathobiology"},{"issue":"8","key":"2023070520003099000_CIT0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/gim.2017.196","article-title":"Somatic TP53 variants frequently confound germ-line testing results","volume":"20","author":"Weitzel","year":"2018","journal-title":"Genet Med"},{"issue":"15_suppl","key":"2023070520003099000_CIT0016","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2020.38.15_suppl.1514","article-title":"Clinical conundrums: developing a strategy for discerning TP53-associated chip and coherent clinical care","volume":"38","author":"Weitzel","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"2023070520003099000_CIT0017","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"issue":"10","key":"2023070520003099000_CIT0018","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/s41375-021-01337-8","article-title":"Clonal hematopoiesis and its emerging effects on cellular therapies","volume":"35","author":"von Bonin","year":"2021","journal-title":"Leukemia"},{"issue":"2","key":"2023070520003099000_CIT0019","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00438-015-1130-7","article-title":"Unrevealed mosaicism in the next-generation sequencing era","volume":"291","author":"Gajecka","year":"2016","journal-title":"Mol Genet Genomics"},{"issue":"1","key":"2023070520003099000_CIT0020","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1038\/s41598-018-25311-0","article-title":"Quantitation of the cellular content of saliva and buccal swab samples","volume":"8","author":"Theda","year":"2018","journal-title":"Sci Rep"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/7\/624\/50825894\/oyad105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/7\/624\/50825894\/oyad105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T20:01:11Z","timestamp":1688587271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/28\/7\/624\/7158600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,5,9]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyad105","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,5,9]]}}}